Dr. Donna Harrison, a prominent OB-GYN and researcher, exposed how the U.S. Food and Drug Administration has manipulated abortion data to make the abortion drug seem safer than what it really is.
The drug, mifepristone, has been used to kill millions of unborn babies since its approval at the end of the Clinton administration. Growing research indicates it is not safe for pregnant mothers either.
In a new interview on The Breakdown podcast, Harrison spoke about why she and other OB-GYNs and emergency room physicians are challenging the FDA’s approval of mifepristone as an abortion drug in a new lawsuit.
Harrison said mifepristone is dangerous for mothers and unborn babies, but the FDA has cleverly manipulated data about complications to make it appear safe.
U.S. Sen. James Lankford, R-Oklahoma, who hosts the podcast, said he felt “shocked” when he learned that the FDA only requires fatal complications from the abortion drug to be reported. The reporting change occurred under the Obama administration.
In other words, “if the woman has to go to the emergency room if she has excessive bleeding, if there are other major complications, even if she is in the ER on life support for days and days and days, if she recovers from that, [the FDA says], ‘Don’t tell us about it. Only tell us if she dies,’” Lankford said.
He wondered if there is a reasonable explanation for why the FDA would not want to track complications from a drug, asking, “Is that typical?”
Harrison said no, the abortion drug is an exception. And because of the lack of reporting, she said doctors cannot provide good information about its risks to their patients.
HELP LIFENEWS SAVE BABIES FROM ABORTION! Please help LifeNews.com with a donation!
“Women have a right to know before they proceed with the procedure — any procedure — what the risks are and what the complications they could face. That’s part of informed consent,” she said.
Even worse, Harrison said the FDA used its intentionally-imposed lack of complication reports to claim the abortion drug is safe – so safe that it can be sold through the mail without a doctor’s supervision.
“You can’t make this stuff up,” Harrison told the podcast. “The FDA has been purposefully … not requiring complications from this drug to be reported so that they could then say, ‘Well, there’s no complications that we know of.’”
Another problem is that, for the few years when the FDA did require complications to be reported, it only required abortionists to do so, she continued. However, research indicates that emergency room doctors take care of more than half of abortion pill complications, Harrison said.
Backing up Harrison’s comments, other emergency room physicians and OB-GYNs have said women are coming to them suffering complications because the abortion industry now can sell abortion pills online and then abandon women to fend for themselves.
The FDA approves mifepristone to abort unborn babies up to about 10 weeks of pregnancy – although some abortionists use it later. It works by blocking the hormone progesterone and basically starving the unborn baby to death. Typically, abortion groups also prescribe a second drug, misoprostol, to induce labor and expel the baby’s body.
In recent years, abortion drugs have been used for more than half of all abortions in the U.S., killing hundreds of thousands of unborn babies annually, according to the Guttmacher Institute.
Studies indicate abortion risks are more common than what abortion activists often claim, with about one in 17 women requiring hospital treatment. A recent study by the Charlotte Lozier Institute found that the rate of abortion-related emergency room visits by women taking the abortion drug increased more than 500 percent between 2002 and 2015.
Another recent study from the University of Toronto, “Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion,” published in the Annals of Internal Medicine, found that one in ten women who took the abortion pill went to the emergency room, according to Pregnancy Help News.
The FDA has linked mifepristone to 28 women’s deaths between 2000 and 2018. At least two more women have died since then, although the number likely is much higher.
